Insider filing · SKYE
Punit Dhillon
Chief Executive Officer
profile →
Skye Bioscience, Inc.
SKYE · Healthcare · 8 filings in 24 months
ticker →
Punit Dhillon sold $412K of Skye Bioscience (SKYE)
Executed Nov 18 2024, disclosed Nov 19 2024, 1 day later.
Value, as filed
$412K
82,546 sh × $4.99
Executed
Nov 18 2024
the trade date, as filed
Disclosed
Nov 19 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PDPunit Dhillon (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Skye Bioscience, Inc. (SKYE). The largest single filing was $412K of SKYE (82,546 sh × $4.99, as filed), executed Nov 18 2024.
The name
SKYEHealthcare · Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→